Fiche publication
Date publication
juillet 2026
Journal
Clinical chemistry and laboratory medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GILLERY Philippe
,
Pr MAHMOUDI Abd-El-Rachid
Tous les auteurs :
Noujaim P, Jaisson S, Pierrard L, Badr S, Gillery P, Mahmoudi R
Lien Pubmed
Résumé
Reliable biomarkers may allow early risk stratification for mortality in older adults. Post-translational modification-derived products (PTMDPs), such as homocitrulline, and the tissue accumulation of advanced glycation end products (AGEs), measured by skin autofluorescence, have been suggested as potential biomarkers of adverse outcomes in older and frail individuals. The aim of this study was to assess their association with 3-year mortality following hospitalisation.
Mots clés
advanced glycation end products, ageing, frailty, homocitrulline, post-translational modification-derived products (PTMDPs)
Référence
Clin Chem Lab Med. 2026 07 2;:
